drugset / Trial / NCT06023212
Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
Phase 1/2
Recruiting
150 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupTriple-blindTreatment
Summary
Massive blood loss occurs in metastatic spinal tumor resection and may cause severe complications. The objective of this study is to investigate whether the use of tranexamic acid will reduce perioperative and postoperative bleeding when compared to those without use of tranexamic acid.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2026-01-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1 g | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 2 g | Intravenous |